Based on recent data, Amneal Pharmaceuticals, Inc. (AMRX) shows an Average True Range (ATR) of 0.4 and an Enterprise Value of 4.53B. Its average trading volume over the past 3 months is 2.62M, indicating liquidity. These fundamental metrics provide insight into AMRX's underlying financial health and market activity.
| ATR | 0.4 |
| Enterprise Value | 4.53B |
| Avg Vol (3 Months) | 2.62M |
| Avg Vol (10 Days) | 1.49M |
Amneal Pharmaceuticals, Inc. (AMRX) technical indicators as of April 4, 2026: the SMA 20 is -0.3%, SMA 50 at 6.29%, and SMA 200 at 38.29%. The RSI 14 value is 55.13, suggesting its current momentum. These technical analysis signals help assess AMRX's price trends and potential future movements.
| SMA 20 | -0.3% |
| SMA 50 | 6.29% |
| SMA 200 | 38.29% |
| RSI 14 | 55.13 |
Amneal Pharmaceuticals, Inc. (AMRX) stock performance overview as of April 4, 2026: The 52-week high is $15.42 (currently -6.03% below), and the 52-week low is $6.68 (currently 116.75% above). Over the past year, AMRX's performance is 60.41%, compared to the S&P 500's 16.47% change.
| 52-Week High | 15.42 |
| 52-Week High Chg | -6.03% |
| 52-Week Low | 6.68 |
| 52-Week Low Chg | +116.75% |
| S&P 500 52-Week Chg | 16.47% |
According to market data, Amneal Pharmaceuticals, Inc. (AMRX) stock's recent performance metrics show that over the last month, AMRX is 8.11%, with a Year-to-Date (YTD) performance of 5.79%. Over the past year, the stock has seen a 60.41% change. These figures summarize AMRX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 12.73 | 13.98 | 15.42 | 15.42 | 15.42 | 15.42 |
| Low | 11.83 | 11.71 | 11.71 | 9.56 | 6.68 | 11.71 |
| Performance | +2.70% | +8.11% | +34.38% | +68.52% | +60.41% | +5.79% |
According to current financial data, AMRX stock's P/E (TTM) ratio is 54.27, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for AMRX, including P/S (1.30), P/B (-55.24), and P/FCF (16.57), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | AMRX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 54.27 | -1.22 | 13.14 | 32.59 |
| P/S (TTM) | 1.3 | 3.69 | 6.11 | 5.98 |
| P/B (TTM) | -55.24 | 4.72 | 25.72 | 4.73 |
| P/FCF (TTM) | 16.57 | -9.29 | 66.93 | 32.89 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep